Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

José Portugal

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Biopolymers|June 17, 2020
Insights into DNA-drug interactions in the era of omicsJosé Portugal
Current Medicinal Chemistry. Anti-Cancer Agents|October 8, 2003
Chartreusin, elsamicin A and related anti-cancer antibioticsJosé Portugal
Biochemical Pharmacology|July 25, 2018
Challenging transcription by DNA-binding antitumor drugsJosé Portugal
BMC Pharmacology|September 18, 2009
Evaluation of molecular descriptors for antitumor drugs with respect to noncovalent binding to DNA and antiproliferative activityJosé Portugal
Pharmacology & Therapeutics|June 5, 2024
Mithramycin and its analogs: Molecular features and antitumor actionJosé Portugal
Journal of Biomolecular Structure & Dynamics|February 15, 2002
Occurrence of DNA sequences specifically recognized by drugs in human promotersSylvia Mansilla, José Portugal
Current Medicinal Chemistry|September 6, 2016
Noncovalent Binding to DNA: Still a Target in Developing Anticancer AgentsJosé Portugal, Francisca Barceló
FEBS Letters|October 12, 2004
Elsamicin A binding to DNA. A comparative thermodynamic characterizationFrancisca Barceló, José Portugal
Biochimie|January 30, 2008
Sp1 transcription factor as a target for anthracyclines: effects on gene transcriptionSylvia Mansilla, José Portugal
Archives of Biochemistry and Biophysics|April 27, 2005
Apoptosis and cell recovery in response to oxidative stress in p53-deficient prostate carcinoma cellsMarc Bataller, José Portugal
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Biopolymers|June 17, 2020
Insights into DNA-drug interactions in the era of omicsJosé Portugal
Current Medicinal Chemistry. Anti-Cancer Agents|October 8, 2003
Chartreusin, elsamicin A and related anti-cancer antibioticsJosé Portugal
Biochemical Pharmacology|July 25, 2018
Challenging transcription by DNA-binding antitumor drugsJosé Portugal
BMC Pharmacology|September 18, 2009
Evaluation of molecular descriptors for antitumor drugs with respect to noncovalent binding to DNA and antiproliferative activityJosé Portugal
Pharmacology & Therapeutics|June 5, 2024
Mithramycin and its analogs: Molecular features and antitumor actionJosé Portugal
Journal of Biomolecular Structure & Dynamics|February 15, 2002
Occurrence of DNA sequences specifically recognized by drugs in human promotersSylvia Mansilla, José Portugal
Current Medicinal Chemistry|September 6, 2016
Noncovalent Binding to DNA: Still a Target in Developing Anticancer AgentsJosé Portugal, Francisca Barceló
FEBS Letters|October 12, 2004
Elsamicin A binding to DNA. A comparative thermodynamic characterizationFrancisca Barceló, José Portugal
Biochimie|January 30, 2008
Sp1 transcription factor as a target for anthracyclines: effects on gene transcriptionSylvia Mansilla, José Portugal
Archives of Biochemistry and Biophysics|April 27, 2005
Apoptosis and cell recovery in response to oxidative stress in p53-deficient prostate carcinoma cellsMarc Bataller, José Portugal
Pageof 5